These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20521324)

  • 1. A comparison of statistical approaches used to evaluate change in cognitive function following pharmacologic challenge: an example with lorazepam.
    Pietrzak RH; Fredrickson A; Snyder PJ; Maruff P
    Hum Psychopharmacol; 2010; 25(4):335-41. PubMed ID: 20521324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute lorazepam effects on neurocognitive performance.
    Loring DW; Marino SE; Parfitt D; Finney GR; Meador KJ
    Epilepsy Behav; 2012 Nov; 25(3):329-33. PubMed ID: 23103305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated Phase I study.
    Collie A; Darekar A; Weissgerber G; Toh MK; Snyder PJ; Maruff P; Huggins JP
    Contemp Clin Trials; 2007 Jul; 28(4):391-400. PubMed ID: 17267292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lorazepam effects on Word Memory Test performance: a randomized, double-blind, placebo-controlled, crossover trial.
    Loring DW; Marino SE; Drane DL; Parfitt D; Finney GR; Meador KJ
    Clin Neuropsychol; 2011 Jul; 25(5):799-811. PubMed ID: 21756210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lorazepam on visual perceptual abilities.
    Pompéia S; Pradella-Hallinan M; Manzano GM; Bueno OF
    Hum Psychopharmacol; 2008 Apr; 23(3):183-92. PubMed ID: 18318455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
    Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ
    Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine.
    Fredrickson A; Snyder PJ; Cromer J; Thomas E; Lewis M; Maruff P
    Hum Psychopharmacol; 2008 Jul; 23(5):425-36. PubMed ID: 18421801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sedation and memory: studies with a histamine H-1 receptor antagonist.
    Turner C; Handford AD; Nicholson AN
    J Psychopharmacol; 2006 Jul; 20(4):506-17. PubMed ID: 16401664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and CNS pharmacodynamics of the 5-HT1A agonist buspirone in humans following acute L-tryptophan depletion challenge.
    Jagannathan V; Venitz J
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):351-62. PubMed ID: 9379784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technological evaluation and equivalence assessment of lorazepam tablets in rabbits.
    Ventura CA; Giannone I; Musumeci T; Pignatello R; Puglisi G
    Pharmazie; 2007 Jul; 62(7):515-8. PubMed ID: 17718192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine-induced reduction in activity mirrors decrements in cognitive and psychomotor performance.
    Dawson J; Boyle J; Stanley N; Johnsen S; Hindmarch I; Skene DJ
    Hum Psychopharmacol; 2008 Oct; 23(7):605-13. PubMed ID: 18570226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence study of two different tablet formulations of donepezil using truncated areas under the curve. A single-center, single-dose, randomized, open-label, 2-way crossover study under fasting conditions.
    Almeida S; Filipe A; Neves R; Desjardins I; Shink E; Castillo A
    Arzneimittelforschung; 2010; 60(3):116-23. PubMed ID: 20422942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers.
    Allain H; Tessier C; Bentué-Ferrer D; Tarral A; Le Breton S; Gandon M; Bouhours P
    Psychopharmacology (Berl); 2003 Feb; 165(4):419-29. PubMed ID: 12459926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies on the effects of the combination drug lorazepam plus diphenhydramine (Somnium) versus lorazepam on the noopsyche, thymopsyche and psychophysiology in nonorganic insomnia related to generalized anxiety disorder.
    Grünberger J; Saletu B; Linzmayer L; Böck G; Weissgram S; Brandstaätter N; Frey R; Saletu-Zyhlarz G
    Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):645-54. PubMed ID: 9500129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the assessment of dose proportionality: a comparison of two slope approaches.
    Cheng B; Chow SC; Su WL
    J Biopharm Stat; 2006 May; 16(3):385-92. PubMed ID: 16724492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of an acute challenge with d-amphetamine to model cognitive improvement in chronic schizophrenia.
    Pietrzak RH; Snyder PJ; Maruff P
    Hum Psychopharmacol; 2010; 25(4):353-8. PubMed ID: 20521327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncated areas under the curve in the assessment of pioglitazone bioequivalence. Data from a single-center, single-dose, randomized, open-label, 2-way cross-over bioequivalence study of two formulations of pioglitazone 45 mg tablets under fasting conditions.
    Almeida S; Filipe A; Neves R; Pinho C; Pedroso P; Castillo A; Trabelsi F
    Arzneimittelforschung; 2011; 61(1):32-9. PubMed ID: 21355444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A statistical approach for classifying change in cognitive function in individuals following pharmacologic challenge: an example with alprazolam.
    Maruff P; Werth J; Giordani B; Caveney AF; Feltner D; Snyder PJ
    Psychopharmacology (Berl); 2006 May; 186(1):7-17. PubMed ID: 16572266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.